Serum Institute Of India
-
{
- All
- News
- Videos
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
Adani Family Tops Most Valuable First-Generation Indian Family Businesses For Second Year Running
The Adani family is led by Gautam Adani and the business' valuation of Rs 14 lakh crore comes from the combined valuation of Adani Enterprises, Adani Ports, and other group companies
-
CCI Approves TPG's Stake Acquisition In Schott Poonawalla From Serum Institute of India
CCI clears TPG's proposal to acquire stake in Schott Poonawalla
-
From Serum Institute Of India, Zoho Corp To Zerodha: Top 10 Bootstrapped Companies In India
Serum Institute of India, led by CEO Adar Poonawalla, tops the list of India's most valuable bootstrapped companies, with a valuation of Rs 2.11 lakh crore, followed closely by Zoho Corp.
-
From Serum Institute Of India, Zoho Corp To Zerodha: Top 10 Bootstrapped Companies In India
Serum Institute of India, led by CEO Adar Poonawalla, tops the list of India's most valuable bootstrapped companies, with a valuation of Rs 2.11 lakh crore, followed closely by Zoho Corp.
-
Work-Hour Debate: Adar Poonawalla Calls For Quality Over Quantity
The Serum Institute CEO claims that the company adheres to standard eight-hour shifts.
-
Work-Hour Debate: Adar Poonawalla Calls For Quality Over Quantity
The Serum Institute CEO claims that the company adheres to standard eight-hour shifts.
-
Davos 2025: Adar Poonawalla Talks Malaria Vaccines, Bollywood Debut And More
Serum Institute is 'trying to reduce malaria in countries in Africa by providing vaccines that can save lives', the CEO says.
-
Davos 2025: Adar Poonawalla Talks Malaria Vaccines, Bollywood Debut And More
Serum Institute is 'trying to reduce malaria in countries in Africa by providing vaccines that can save lives', the CEO says.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
India's Bioeconomy Hits $151 Billion Mark, Contributes 4.25% To GDP: Report
India's bioeconomy reaches valuation of USD 151 bn, contributes 4.25 pc to GDP: Report
-
India's Bioeconomy Hits $151 Billion Mark, Contributes 4.25% To GDP: Report
India's bioeconomy reaches valuation of USD 151 bn, contributes 4.25 pc to GDP: Report
-
Serum Institute Developing Mpox Vaccine Amid Rising Global Concerns
Hopefully, we'll have positive news to share within a year's time, Adar Poonawalla said in an exclusive comment to NDTV Profit.
-
Serum Institute Debuts 'High Efficacy' Malaria Vaccine In West Africa
It was officially rolled out on Monday when Cote d’Ivoire in West Africa became the first country to begin administering it.
-
Serum Institute And Oxford Partner For Bundibugyo Ebola Vaccine Clinical Trials
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly manufacture vaccine doses and begin clinical trials.
-
Adani Family Tops Most Valuable First-Generation Indian Family Businesses For Second Year Running
The Adani family is led by Gautam Adani and the business' valuation of Rs 14 lakh crore comes from the combined valuation of Adani Enterprises, Adani Ports, and other group companies
-
CCI Approves TPG's Stake Acquisition In Schott Poonawalla From Serum Institute of India
CCI clears TPG's proposal to acquire stake in Schott Poonawalla
-
From Serum Institute Of India, Zoho Corp To Zerodha: Top 10 Bootstrapped Companies In India
Serum Institute of India, led by CEO Adar Poonawalla, tops the list of India's most valuable bootstrapped companies, with a valuation of Rs 2.11 lakh crore, followed closely by Zoho Corp.
-
From Serum Institute Of India, Zoho Corp To Zerodha: Top 10 Bootstrapped Companies In India
Serum Institute of India, led by CEO Adar Poonawalla, tops the list of India's most valuable bootstrapped companies, with a valuation of Rs 2.11 lakh crore, followed closely by Zoho Corp.
-
Work-Hour Debate: Adar Poonawalla Calls For Quality Over Quantity
The Serum Institute CEO claims that the company adheres to standard eight-hour shifts.
-
Work-Hour Debate: Adar Poonawalla Calls For Quality Over Quantity
The Serum Institute CEO claims that the company adheres to standard eight-hour shifts.
-
Davos 2025: Adar Poonawalla Talks Malaria Vaccines, Bollywood Debut And More
Serum Institute is 'trying to reduce malaria in countries in Africa by providing vaccines that can save lives', the CEO says.
-
Davos 2025: Adar Poonawalla Talks Malaria Vaccines, Bollywood Debut And More
Serum Institute is 'trying to reduce malaria in countries in Africa by providing vaccines that can save lives', the CEO says.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
India's Bioeconomy Hits $151 Billion Mark, Contributes 4.25% To GDP: Report
India's bioeconomy reaches valuation of USD 151 bn, contributes 4.25 pc to GDP: Report
-
India's Bioeconomy Hits $151 Billion Mark, Contributes 4.25% To GDP: Report
India's bioeconomy reaches valuation of USD 151 bn, contributes 4.25 pc to GDP: Report
-
Serum Institute Developing Mpox Vaccine Amid Rising Global Concerns
Hopefully, we'll have positive news to share within a year's time, Adar Poonawalla said in an exclusive comment to NDTV Profit.
-
Serum Institute Debuts 'High Efficacy' Malaria Vaccine In West Africa
It was officially rolled out on Monday when Cote d’Ivoire in West Africa became the first country to begin administering it.
